The high price of Ozempic is pushing many to unregulated, copycat drugs for weight loss

France Nouvelles Nouvelles

The high price of Ozempic is pushing many to unregulated, copycat drugs for weight loss
France Dernières Nouvelles,France Actualités
  • 📰 YahooNews
  • ⏱ Reading Time:
  • 55 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 25%
  • Publisher: 59%

Novo Nordisk, the sole manufacturer of Ozempic and the patent-holder of semaglutide, said it does not provide the ingredient to pharmacies, leading some experts to question where pharmacies are sourcing the drug — and whether it is semaglutide at all.

When Robin Langois, 58, was prescribed the weight-loss drug Wegovy last year, she couldn’t afford theBut she later discovered on TikTok that people could get their hands on what appeared to be the drug’s active ingredient, semaglutide, from compounding pharmacies for a fraction of the price.

Novo Nordisk, the sole manufacturer of Ozempic and Wegovy and the patent-holder of semaglutide, said in a statement that it does not provide the ingredient to these pharmacies, leading some experts to question where pharmacies are sourcing the drug — and whether it is semaglutide at all. The FDA will also grant exemptions that allow compounding pharmacists to make certain medications if there is a shortage, said Jeremy Kahn, a spokesperson for the agency.Dr. Chris McGowan, who runs a weight loss clinic in Cary, North Carolina, has noticed that compounded versions of Wegovy and Ozempic are growing in popularity.

The weekly injection, which she received at a wellness center, made her nauseous, and she only lost about 15 pounds while taking it."I've always wanted to go get it tested to see what it actually is, but I don't know the process," Mills said. Compounding pharmacists could also be purchasing high doses of semaglutide from wholesalers and then separating it into smaller dosages or mixing it with other drug ingredients, he said.

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

YahooNews /  🏆 380. in US

France Dernières Nouvelles, France Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

The high price of Ozempic is pushing many to unregulated, copycat drugs for weight lossThe high price of Ozempic is pushing many to unregulated, copycat drugs for weight lossSome compounding pharmacies are offering what they say are generic versions of the drugs, which have soared in popularity for weight loss.
Lire la suite »

How do Ozempic and Wegovy help with weight loss? And how much can you expect to lose?How do Ozempic and Wegovy help with weight loss? And how much can you expect to lose?Wegovy is approved for weight loss by the U.S. Food and Drug Administration, while Ozempic is not, though many people are using it off-label for that purpose.
Lire la suite »

People are buying copycat versions of Ozempic and Wegovy. Is that safe?People are buying copycat versions of Ozempic and Wegovy. Is that safe?Some compounding pharmacies are offering what they say are generic versions of the drugs, which have soared in popularity for weight loss.
Lire la suite »

Novo Nordisk's diabetes drug Ozempic back in supply in US after months of shortageNovo Nordisk's diabetes drug Ozempic back in supply in US after months of shortageNovo Nordisk's best-selling diabetes treatment drug Ozempic is back on the shelves in the United States after months of shortage, the U.S. Food and Drug Administration (FDA) website showed on Friday.
Lire la suite »

Here's the real reason there was a shortage of Ozemipic. Hint: It's not the weight loss craze.Ozempic, a diabetes drug, is all the rage for celebrities looking to lose a quick pound. But medically speaking, it's not for everyone.
Lire la suite »

Ozempic craze, Sweetwater Rattlesnake Roundup and Moses Rose’s standoff top week's headlinesSpec’s acquisition of an exemption allowing it to sell liquor and a local Powerball winner also among week’s most popular stories.
Lire la suite »



Render Time: 2025-03-09 17:04:22